Eric Legangneux

Person

Levallois-Perret, FR

People

Patents Grantslast 30 patents

Information Patent Grant
Treatment of autoimmune disease in a patient receiving additionally...
- Patent number 11,944,602
- Issue date Apr 2, 2024
- Novartis AG
- Eric Legangneux
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
S1P MODULATOR IMMEDIATE RELEASE DOSAGE REGIMEN
- Publication number 20250041266
- Publication date Feb 6, 2025
- Novartis AG
- Philippe Michel Rene Bouillot
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IDENTIFYING PATIENT RESPONSE TO S1P RECEPTOR MODULATOR ADMINISTRATION
- Publication number 20240270688
- Publication date Aug 15, 2024
- Novartis AG
- Hubert Borell
- G01 - MEASURING TESTING
Information Patent Application
TREATMENT OF AUTOIMMUNE DISEASE IN A PATIENT RECEIVING ADDITIONALLY...
- Publication number 20230355577
- Publication date Nov 9, 2023
- Novartis AG
- Eric Legangneux
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SIP MODULATOR IMMEDIATE RELEASE DOSAGE REGIMEN
- Publication number 20220016076
- Publication date Jan 20, 2022
- Novartis AG
- Eric Legangneux
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF AUTOIMMUNE DISEASE IN A PATIENT RECEIVING ADDITIONALLY...
- Publication number 20220008385
- Publication date Jan 13, 2022
- Novartis AG
- Eric Legangneux
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IDENTIFYING PATIENT RESPONSE TO S1P RECEPTOR MODULATOR ADMINISTRATION
- Publication number 20210147354
- Publication date May 20, 2021
- Novartis AG
- Hubert Borell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF AUTOIMMUNE DISEASE IN A PATIENT RECEIVING ADDITIONALLY...
- Publication number 20200383947
- Publication date Dec 10, 2020
- Novartis AG
- Eric Legangneux
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Dosing Regimen of Siponimod
- Publication number 20200316021
- Publication date Oct 8, 2020
- Novartis AG
- Jang-Ho Cha
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Dosing Regimen of Siponimod
- Publication number 20200306222
- Publication date Oct 1, 2020
- Novartis AG
- Jang-Ho Cha
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IDENTIFYING PATIENT RESPONSE TO S1P RECEPTOR MODULATOR ADMINISTRATION
- Publication number 20190135744
- Publication date May 9, 2019
- Novartis AG
- Hubert Borell
- G01 - MEASURING TESTING
Information Patent Application
SIP MODULATOR IMMEDIATE RELEASE DOSAGE REGIMEN
- Publication number 20190054065
- Publication date Feb 21, 2019
- Novartis AG
- Eric Legangneux
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF AUTOIMMUNE DISEASE IN A PATIENT RECEIVING ADDITIONALLY...
- Publication number 20190038599
- Publication date Feb 7, 2019
- Novartis AG
- Eric Legangneux
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Dosage Regimen of Diaryl Sulfide Derivatives
- Publication number 20180161290
- Publication date Jun 14, 2018
- Novartis AG
- Peter Gergely
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF AUTOIMMUNE DISEASE IN A PATIENT RECEIVING ADDITIONALLY...
- Publication number 20180042895
- Publication date Feb 15, 2018
- Novartis AG
- Eric Legangneux
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IDENTIFYING PATIENT RESPONSE TO S1P RECEPTOR MODULATOR ADMINISTRATION
- Publication number 20170320820
- Publication date Nov 9, 2017
- Novartis AG
- Hubert Borell
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Dosage Regimen of Diaryl Sulfide Derivatives
- Publication number 20170119702
- Publication date May 4, 2017
- Novartis AG
- Peter Gergely
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SIP MODULATOR IMMEDIATE RELEASE DOSAGE REGIMEN
- Publication number 20170027907
- Publication date Feb 2, 2017
- Eric Legangneux
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IDENTIFYING PATIENT RESPONSE TO S1P RECEPTOR MODULATOR ADMINISTRATION
- Publication number 20160046573
- Publication date Feb 18, 2016
- Novartis AG
- Hubert BORELL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Dosage Regimen of Diaryl Sulfide Derivatives
- Publication number 20140336265
- Publication date Nov 13, 2014
- Novartis AG
- Peter Gergely
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Dosage Regimen of an S1P Receptor Agonist
- Publication number 20130281712
- Publication date Oct 24, 2013
- Eric Legangneux
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Dosage Regimen of Diaryl Sulfide Derivatives
- Publication number 20130210924
- Publication date Aug 15, 2013
- Novartis AG
- Peter Gergely
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Eric Legangneux

Person

Patents Grantslast 30 patents

Treatment of autoimmune disease in a patient receiving additionally...

Patents Applicationslast 30 patents

S1P MODULATOR IMMEDIATE RELEASE DOSAGE REGIMEN

IDENTIFYING PATIENT RESPONSE TO S1P RECEPTOR MODULATOR ADMINISTRATION

TREATMENT OF AUTOIMMUNE DISEASE IN A PATIENT RECEIVING ADDITIONALLY...

SIP MODULATOR IMMEDIATE RELEASE DOSAGE REGIMEN

TREATMENT OF AUTOIMMUNE DISEASE IN A PATIENT RECEIVING ADDITIONALLY...

IDENTIFYING PATIENT RESPONSE TO S1P RECEPTOR MODULATOR ADMINISTRATION

TREATMENT OF AUTOIMMUNE DISEASE IN A PATIENT RECEIVING ADDITIONALLY...

Dosing Regimen of Siponimod

Dosing Regimen of Siponimod

IDENTIFYING PATIENT RESPONSE TO S1P RECEPTOR MODULATOR ADMINISTRATION

SIP MODULATOR IMMEDIATE RELEASE DOSAGE REGIMEN

TREATMENT OF AUTOIMMUNE DISEASE IN A PATIENT RECEIVING ADDITIONALLY...

Dosage Regimen of Diaryl Sulfide Derivatives

TREATMENT OF AUTOIMMUNE DISEASE IN A PATIENT RECEIVING ADDITIONALLY...

IDENTIFYING PATIENT RESPONSE TO S1P RECEPTOR MODULATOR ADMINISTRATION

Dosage Regimen of Diaryl Sulfide Derivatives

SIP MODULATOR IMMEDIATE RELEASE DOSAGE REGIMEN

IDENTIFYING PATIENT RESPONSE TO S1P RECEPTOR MODULATOR ADMINISTRATION

Dosage Regimen of Diaryl Sulfide Derivatives

Dosage Regimen of an S1P Receptor Agonist

Dosage Regimen of Diaryl Sulfide Derivatives